Abilene Motor Express brand to merge with sister company
The carrier’s brand is merging under Swift Transportation, nearly eight years after Knight Transportation acquired the business. Continue reading →
FedEx Freight targets strategic density in spin-off
“We believe door count — not terminal count — is the most relevant measure of our network capacity,” the business said in a key securities filing ahead of the June spinoff. Continue reading →
Barents Sea oil discovery’s potential strengthened by appraisal ops
Vår Energi, a Norwegian oil and gas operator, has finished drilling an appraisal well related to an oil discovery in the Barents Sea, confirming reservoir quality and adding recoverable volumes. The post Barents Sea oil discovery’s potential strengthened by appraisal ops appeared first on...
Chevron signs off on Mediterranean field expansion for gas production uptick
Chevron Mediterranean Limited (CML), a subsidiary of the U.S.-headquartered Chevron, and its partners have given the green light for a planned expansion of gas export capacity from a giant natural gas field project off the coast of Israel. The post Chevron signs off on Mediterranean field...
STAAR CEO exits after company rejects Alcon buyout
An activist investor has reshaped the board, securing the departures of STAAR’s CEO and chair. Continue reading →
Intuitive says general surgery, acute care fuel US robot momentum
CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving greater utilization than the earlier Xi model. Continue reading →
Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project
Bio-Sourcing and Zerion Pharma have announced that their collaboration to develop an oral form of the monoclonal antibody trastuzumab for breast cancer has received 1.3m euros in funding from EUREKA Eurostars. The collaboration combines Bio-Sourcing’s BioMilk platform, designed to transport...Secure Your Spot at RSAC 2026 Conference
Continue reading →
Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech
Arkin Capital has announced the closing of Arkin Bio Ventures III, a $100m fund designed to invest in pre-clinical and early clinical-stage biotechnology companies whose work has the potential to address high unmet medical need. Arkin Bio Ventures III builds on two previous funds, Arkin Bio...